MPM Capital, a San Francisco venture capital firm focused on healthcare investments, has partnered with Indian biotechnology company Reliance Life Sciences to invest in India.
VentureWire has the story (sub required), and says it is significant because it is one of the first commitments to healthcare in India by a U.S. venture firm. Others, such as SV Life Sciences, have done so selectively.
We mentioned MPM’s latest fund here.
Trackback URL
5 Comments
-
rk said:
India has great network of generic drug companies and pool of scientist, who happen to be cheaper, and available in quantity as well. This move by Mpm makes sense
-
vvxxzemgzp said:
Hello! Good Site! Thanks you! lthskuomnysyaf
-
lol said:
